Baldwin Wealth Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-35
| Closed | -$498 | – | 918 |
|
|
2024
Q3 | $498 | Buy |
+35
| New | +$498 | ﹤0.01% | 1030 |
|
|
2024
Q2 | – | Sell |
-35
| Closed | -$486 | – | 822 |
|
|
2024
Q1 | $486 | Sell |
35
-2,000
| -98% | -$27.8K | ﹤0.01% | 672 |
|
|
2023
Q4 | $29K | Hold |
2,035
| – | – | ﹤0.01% | 450 |
|
|
2023
Q3 | $31.5K | Hold |
2,035
| – | – | ﹤0.01% | 451 |
|
|
2023
Q2 | $32K | Hold |
2,035
| – | – | ﹤0.01% | 473 |
|
|
2023
Q1 | $33.5K | Hold |
2,035
| – | – | ﹤0.01% | 472 |
|
|
2022
Q4 | $31.7K | Buy |
2,035
+2,000
| +5,714% | +$31.2K | ﹤0.01% | 478 |
|
|
2022
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 652 |
|
|
2022
Q2 | $0 | Hold |
35
| – | – | ﹤0.01% | 703 |
|
|
2022
Q1 | $1K | Hold |
35
| – | – | ﹤0.01% | 659 |
|
|
2021
Q4 | $0 | Hold |
35
| – | – | ﹤0.01% | 654 |
|
|
2021
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 637 |
|
|
2021
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 651 |
|
|
2021
Q1 | $1K | Hold |
35
| – | – | ﹤0.01% | 617 |
|
|
2020
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 545 |
|
|
2020
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 529 |
|
|
2020
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 523 |
|
|
2020
Q1 | $1K | Hold |
35
| – | – | ﹤0.01% | 539 |
|
|
2019
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 533 |
|
|
2019
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 512 |
|
|
2019
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 502 |
|
|
2019
Q1 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 501 |
|